Difference between revisions of "NHLBI Exome Sequencing Project"
From Genome Analysis Wiki
Jump to navigationJump to search (Created page with 'The '''NHLBI Exome Sequencing Project''' is using deep whole exome resequencing of >7,000 individuals to study genetic contributions to the risk of several heart, lung and blood …') |
|||
| Line 13: | Line 13: | ||
Different definitions for different cohort sets as outlined below: | Different definitions for different cohort sets as outlined below: | ||
| − | Phase 1 LungGO - ccds_2008 | + | * Phase 1 LungGO - ccds_2008 |
| − | Phase 1 WHISPGO - BMI/T2D - ccds_2008 | + | * Phase 1 WHISPGO - BMI/T2D - ccds_2008 |
| − | Phase 1 HeartGO -LDL- uwrefSeq_2009 | + | * Phase 1 HeartGO -LDL- uwrefSeq_2009 |
| − | Phase 2 HeartGO/WISPGO - EOS - v2refseq2010 | + | * Phase 2 HeartGO/WISPGO - EOS - v2refseq2010 |
Latest revision as of 21:44, 14 September 2010
The NHLBI Exome Sequencing Project is using deep whole exome resequencing of >7,000 individuals to study genetic contributions to the risk of several heart, lung and blood phenotypes.
All sequence data generated by the project is being deposited into dbGap. Generation of sequence data is taking place at the University of Washington (overseen by Jay Shendure and Debbie Nickerson) and at the Broad Institute (overseen by Stacey Gabriel).
Regions Targeted For Sequencing
University of Washington
The exact coding regions being sequenced are evolving overtime. The exome definitions used in the project are available from:
http://droog.gs.washington.edu/~bard/exome_defs/
Different definitions for different cohort sets as outlined below:
- Phase 1 LungGO - ccds_2008
- Phase 1 WHISPGO - BMI/T2D - ccds_2008
- Phase 1 HeartGO -LDL- uwrefSeq_2009
- Phase 2 HeartGO/WISPGO - EOS - v2refseq2010
